Campbell Rebecca K, Schulze Kerry J, Shaikh Saijuddin, Mehra Sucheta, Ali Hasmot, Wu Lee, Raqib Rubhana, Baker Sarah, Labrique Alain, West Keith P, Christian Parul
*Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD †JiVitA Project, Gaibandha, Bangladesh ‡icddr,b, Mohakhali, Dhaka, Bangladesh.
J Pediatr Gastroenterol Nutr. 2017 Jul;65(1):40-46. doi: 10.1097/MPG.0000000000001557.
Environmental enteric dysfunction (EED) may inhibit growth and development in low- and middle-income countries, but available assessment methodologies limit its study. In rural Bangladesh, we measured EED using the widely used lactulose mannitol ratio (L:M) test and a panel of intestinal and systemic health biomarkers to evaluate convergence among biomarkers and describe risk factors for EED.
In 539 18-month-old children finishing participation in a randomized food supplementation trial, serum, stool, and urine collected after lactulose and mannitol dosing were analyzed for biomarkers of intestinal absorption, inflammation, permeability and repair, and systemic inflammation. EED scores for each participant were developed using principal component analysis and partial least squares regression. Associations between scores and L:M and with child sociodemographic and health characteristics were evaluated using regression analysis.
EED prevalence (L:M > 0.07) was 39.0%; 60% had elevated acute phase proteins (C-reactive protein >5 mg/L or α-1 acid glycoprotein >100 mg/dL). Correlations between intestinal biomarkers were low, with the highest between myeloperoxidase and α-1 antitrypsin (r = 0.33, P < 0.01), and biomarker values did not differ by supplementation history. A 1-factor partial least squares model with L:M as the dependent variable explained only 8.6% of L:M variability. In adjusted models, L:M was associated with child sex and socioeconomic status index, whereas systemic inflammation was predicted mainly by recent illness, not EED.
Impaired intestinal health is widespread in this setting of prevalent stunting, but a panel of serum and stool biomarkers demonstrated poor agreement with L:M. Etiologies of intestinal and systemic inflammation are likely numerous and complex in resource-poor settings, underscoring the need for a better case definition with corresponding diagnostic methods to further the study of EED.
环境肠道功能障碍(EED)可能会抑制低收入和中等收入国家儿童的生长发育,但现有的评估方法限制了对其的研究。在孟加拉国农村地区,我们使用广泛应用的乳果糖-甘露醇比率(L:M)试验以及一组肠道和全身健康生物标志物来测量EED,以评估生物标志物之间的一致性,并描述EED的风险因素。
在539名完成一项随机食物补充试验的18个月大儿童中,对服用乳果糖和甘露醇后收集的血清、粪便和尿液进行分析,以检测肠道吸收、炎症、通透性和修复以及全身炎症的生物标志物。使用主成分分析和偏最小二乘回归为每位参与者制定EED评分。使用回归分析评估评分与L:M之间以及与儿童社会人口统计学和健康特征之间的关联。
EED患病率(L:M>0.07)为39.0%;60%的儿童急性期蛋白升高(C反应蛋白>5mg/L或α-1酸性糖蛋白>100mg/dL)。肠道生物标志物之间的相关性较低,髓过氧化物酶与α-1抗胰蛋白酶之间的相关性最高(r=0.33,P<0.01),且生物标志物值在补充史方面无差异。以L:M为因变量的单因素偏最小二乘模型仅解释了L:M变异性的8.6%。在调整后的模型中,L:M与儿童性别和社会经济地位指数相关,而全身炎症主要由近期疾病预测,而非EED。
在这种发育迟缓普遍存在的环境中,肠道健康受损情况普遍,但一组血清和粪便生物标志物与L:M的一致性较差。在资源匮乏的环境中,肠道和全身炎症的病因可能众多且复杂,这突出表明需要更好的病例定义及相应的诊断方法,以推动对EED的研究。